L26/P-431 Patient-Reported Barriers to the Timely Diagnosis and Ongoing Management of Polycystic Ovary Syndrome: A Scoping Review
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.765 ↗Kurz gefasst
Scoping Review in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Chen und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What patient-reported and EHR-derived barriers contribute to delayed diagnosis and suboptimal management of PCOS in the United States? Summary answer Provider knowledge gaps, insufficient treatment explanations, and inadequate mental health support were the most frequently reported barriers associated with diagnostic delays and suboptimal management. What is known already Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-aged individuals, affecting up to 27% women globally, with studies reporting higher prevalence in adolescents due to diagnostic heterogeneity and overlapping pubertal features that resemble PCOS. Despite its substantial reproductive, metabolic, and psychological burden, international reviews highlight diagnostic delays, inconsistent application of diagnostic criteria, and fragmented care pathways. However, healthcare system heterogeneity limits evaluation of system-level barriers, underscoring the need for a U.S.-focused analysis to enable a more consistent assessment of how healthcare structures influence PCOS diagnosis and management and inform strategies to support timely, patient-centered PCOS care. Study design, size, duration The scoping review follows the Systematic Review and Meta-analysis extension for Scoping Reviews (PRISMA-ScR) checklist. A total of 819 records from PubMed, Web of Science, EMBASE, Scopus, and 140 records from Google Scholar were identified in October 2025. Filters included publications from the last 10 years (2015–October 2025) to capture evidence reflecting current diagnostic criteria and patient experiences following updates to PCOS guidelines. Studies were screened on Covidence and 12 studies met the inclusion criteria. Participants/materials, setting, methods 8 of the 12 studies included were cross-sectional surveys with patients recruited from varying approaches including in-person outreach, online platforms, large hospital networks, and academic healthcare settings with PCOS diagnosis either physician or self-reported. Three studies were retrospective cohort or observational studies using electronic health records, applying Rotterdam or NIH criteria. One study was a narrative review, and one additionally surveyed OB/GYNs and endocrinologists. Main results and the role of chance Provider knowledge gaps were pervasive, with 27.2% of gynecologists and reproductive endocrinologists uncertain of PCOS diagnostic criteria, contributing to misdiagnoses and mean delays of 34–36 months. Among cohorts, 30.8% of patients had to wait ≥ 4 years for diagnosis and 33% reported prior misdiagnoses. Patients reported difficulties in managing multiple unexplained symptoms, including weight gain, menstrual irregularities, dermatologic concerns, and mood or anxiety-related challenges with 51.2% dissatisfied with recommended treatment options. Only half (52.7%) received counseling for PCOS-related pregnancy complications, 51.2% were dissatisfied with recommended treatment options while overweight and obese patients had lower odds of missed diagnoses compared to lean and normal BMI individuals (71% CI, 0.51–0.98). Publicly insured and uninsured patients, rural “cold spot” residents, and urban residents with transportation barriers faced limited access to specialists. Racial disparities persisted post-adjustment of age and socioeconomic determinants. Compared to White Hispanic women, African Americans faced higher missed diagnosis (OR 1.69; 95% CI, 1.28–2.24), longer diagnosis delays (averaging 153.3 days), and Black patients were less likely to receive prescriptions compared with White or Asian patients (OR 0.75). Non-English speakers also experienced increased missed diagnoses (OR 1.34; 95% CI, 1.03–1.75). Limitations, reasons for caution Interpretation is limited by heterogenous recruitment strategies, inconsistent diagnostic criteria including the reliance on self-reported surveys, which constrains quantitative synthesis. Community-based sampling may overrepresent younger, digitally engaged participants while underrepresenting undiagnosed or underserved populations, potentially limiting generalizability across healthcare settings. Wider implications of the findings PCOS diagnostic delays and mismanagement reflects insufficient REI training, phenotypic bias, and fragmented guideline implementation. Translational impact requires integrating cross-speciality training with the recognition of ethnic and morphological heterogeneity, standardised diagnostic algorithms embedded within health systems, telehealth-enabled access, and referral networks to enable timely PCOS management across diverse populations. Trial registration number No
Zitieren
APA
Chen, N., Hameed, N., Jabbour, T., Kim, D., Wong, S., & Dahan, M. (2026). L26/P-431 Patient-Reported Barriers to the Timely Diagnosis and Ongoing Management of Polycystic Ovary Syndrome: A Scoping Review. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.765
Vancouver
Chen N, Hameed N, Jabbour T, Kim D, Wong S, Dahan M. L26/P-431 Patient-Reported Barriers to the Timely Diagnosis and Ongoing Management of Polycystic Ovary Syndrome: A Scoping Review. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.765
BibTeX
@article{Chen2026,
author = {Chen, N. and Hameed, N. and Jabbour, T. and Kim, D. and Wong, S. and Dahan, M.},
title = {L26/P-431 Patient-Reported Barriers to the Timely Diagnosis and Ongoing Management of Polycystic Ovary Syndrome: A Scoping Review},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.765}
}
EUVIMED